Untitled Document

Name 
:  Eric Donn Bateman

Current Position: Professor of Respiratory Medicine, and Head of Division of Pulmonology, Department of Medicine, University of Cape Town
Director, University of Cape Town Lung Institute.

Address: University of Cape Town Lung Institute, PO Box 34560, Groote Schuur, 7937, Cape Town, South Africa  
Telephone (021) 406-6901
Facsimile (021) 406-6902
Email address Eric.Bateman@uct.ac.za 

PROFESSIONAL QUALIFICATIONS

1986: Fellow of Royal College of Physicians (United Kingdom)
1984: Doctor of Medicine (University of Cape Town). Title of thesis: Fibrogenic Mechanisms and Sequence of Collagen Deposition in Pulmonary Fibrosis.
1974: Member of the Royal College of Physicians (United Kingdom)
1973: Diploma of Child Health of Royal College of Physicians (London) and Royal College of Surgeons (England).
1970: MB ChB (University of Cape Town) with honours and distinction in the final professional examinations.

PROFESSIONAL APPOINTMENTS

1998 - current:  Founder and Managing Director of the University of Cape Town Lung Institute.
1996 - current: Professor of Respiratory Medicine and Chief Specialist.
Head: Division of Pulmonology, Department of Medicine, University of Cape Town and Groote Schuur Hospital.
1989 - current: Head, Respiratory Clinic, Groote Schuur Hospital.

AWARDS AND FELLOWSHIPS

2012: European Respiratory Society President’s Award for 2012 in recognition for global contribution to Respiratory Medicine
2011: South African Medical Association. Fellowship in Art and Science of Medicine Award: Gold Medal
2011: Honorary membership of Primary Care Respiratory Group – United Kingdom
2009:   A-rating as Scientist by National Research Foundation (South Africa)
2006:  Fellow of the University of Cape Town
2006: Member of Academy of Science of South Africa
2003:  Honorary Fellow of the South African Thoracic Society

1991:   Ernest Oppenheimer Memorial Travelling Fellowship.
1987:   Continental Ethicals Travelling Lecturer in Pulmonology.
1978:    I.C.I. (SA) Pharmaceuticals Research Fellowship.
1970:    Dowie Dunn Prize and Nestle Prize for Paediatrics in fourth and final years as a medical student.

MEMBERSHIP OF EDITORIAL ADVISORY BOARDS OF SCIENTIFIC PUBLICATIONS*
2012 – current European Respiratory Journal
2011 – current South Africa Respiratory Journal
2010 - current Thorax
2007 - current: Therapeutic Advances in Respiratory Disease
2005 - current: Primary Care Respiratory Care Journal (Journal of the General Practice International Airways Group)
2002 - current: BioMed Central:  Pulmonary Medicine.
2002 - current: COPD: Journal of Chronic Obstructive Pulmonary Disease.
1996 - 2012: Respiration (Associate Editor)
2004 - 2010: Respirology (Journal of the Asian Pacific Society of Respirology)
2005-2007: American Journal of Respiratory and Critical Care Medicine
2001- 2008: Treatments in Respiratory Medicine (formerly Journal of American Journal of Respiratory Medicine).
2003-2007: The International Journal of Tuberculosis and Lung Disease (Associate Editor)
1988-2007: Current Allergy and Clinical Immunology (formerly Current Allergy).
1998-2001: Respiratory Care Matters
1994-2002: Thorax.
1992-1995: Advances in Respiratory Medicine.

MEMBERSHIP OF PROFESSIONAL BODIES AND SOCIETIES*
2011 - current: Honorary membership of Primary Care Respiratory Group – United Kingdom
2005 - current: Member of the Academy of Sciences of South Africa
2005 - current: European Respiratory Society.
2004 - current: Asian Pacific Society of Respirology
1998 - current: South African Medical Association.
1994 - current: National Asthma Education Programme.
1980 - current: American Thoracic Society.
1981 - current: Medical Alumni Club, University of Cape Town.
1988 - current: Critical Care Society of South Africa.
1988 - current: Council on Smoking and Health of Southern Africa.
1988 - current: Allergy Society of South Africa.
1994 - 2000: Interasma (International Association of Asthmology).
1993 - 2008: International Mesothelioma Interest Group.
1993 - 1996: Sleep Society of South Africa.
1986 - 2006: British Thoracic Society.
1984 - 1990: College of Medicine of South Africa (Associate Member).
1980 - 1990: South African Immunology Society (Founder member).
1971 - 1986: Medical Association of South Africa.

INTERNATIONAL ACTIVITIES (since 2000)
2011 - current  Member of Pulmonary Subcommittee, NIH Centres of Excellence for Chronic Non-Communicable Diseases initiative
2011 - current  Member of Respiratory Working Group for South African National Health and Nutrition Epidemiological study
2010 - current: Member of International Advisory Board of the Burden of Obstructive Lung Disease initiative
2010: Reviewer for Wellcome Trust, United Kingdom
2009 – current: ERS representative to Joint ERS/ATS Task Force on Severe Asthma.
2008:  WHO Workshop on Research Priorities for Non-Communicable Diseases – invited member.
2008: WHO Workshop for developing the WHO Package for Essential Non-Communicable Diseases (WHO-PEN).
2007-2011: Member of the Executive Committee of the Global Alliance against Chronic Respiratory Diseases
2005-current: Representative of the American Thoracic Society on the Board of the Global Alliance for Respiratory Diseases (a WHO alliance).
2005- current: Member of International Health Committee of American Thoracic Society.
2008 - 2011: Chair of Board:  Global Initiative for Asthma (GINA).
2002-current: Board member: Global Initiative for Asthma (GINA)
2002-current: Member: Global Initiative for Asthma (GINA) Scientific Committee.
2004-2007: Chair: Scientific Committee of Global Initiative for Asthma.
2002-2005: Chair:  GOAL Study International Steering Committee.
2004-2008: Member of a Joint American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbation Outcomes.
2000 - 2002 Member of Executive Committee of ARIA (Allergic Rhinitis and its Impact on Asthma), a World Health Organisation approved Non-governmental organization.
1998 – 2002:  ATS representative on ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
1999-2002: Member of ATS Communications Committee.

LOCAL PROFESSIONAL ACTIVITIES:
2011-current:
Member of Technical Advisory Group for Non-Communicable Diseases component of the SANHANES 1 project.

PUBLICATIONS

BOOKS AND CHAPTERS IN BOOKS

  1. Bateman ED, Boulet L-P. Bronchodilator therapies for severe asthma. Eur Respir Monograph 2011; 000:1-18.
  2. Dawson R, Bateman ED.  Tuberculosis in Non-HIV Immunosuppressed Patients. In: Tuberculosis: A Comprehensive Clinical Reference. Eds H Simon Schaaf and Alimuddin Zumla. Saunders Elsevier; Europe. 2009 p560-71.
  3. Bateman ED, Jithoo A. Lung Diseases in South Africa: An overview. In: Innate immunity to pulmonary infection. Wiley, Chichester (Novartis Foundation Symposium 279). 2006 p 4-11.
  4. White N,  Bateman ED.  Mesothelioma and Exposure to Asbestos in South Africa: 1962-2000.   In: Mesothelioma.  Eds BWS Robinson and AP Chahinian. Martin Duntiz: London; 2002: 93-110. ISBN 9058231801


Lalloo UG, Bateman ED, Feldman C, Bardin PG, Plit M, Irusen E, O’Brien J. Guidelines for the management of chronic asthma in adults  -  2000 Update. The ALLSA Handbook of Practical Allergy. Republic of South Africa; Ince (Pty) Ltd; 2001:47-67. ISBN 0-620-27422-0.

Bousquet J, van Cauwenberge P, Khaltaev N, on behalf of an expert committee. World Health Organisation Initiative: Allergic Rhinitis and its Impact on Asthma. (ARIA). 2001.  World Health Organisation.
 
Lewis SJ, Ainslie GM, Bateman ED. Efficacy of azathioprine as second-line treatment in Pulmonary Sarcoidosis. In: ’The Golden Book’: Sarcoidosis 1994/1999. Fidenza (Parma): Casa Editrice Mattioli; 2000: 176 – 181.

Bateman ED Pulmonary Effects of rheumatic fever. In: Royal Brompton Colour Handbook of Respiratory Medicine.  Eds R M du Bois and E Alton.  London 1999.

Bateman ED.  Lung Health: Reflections of our Life and Times.  Inaugural Lecture. University of Cape Town New Series.  No.  203, August 133, 1997.

Bateman ED, Louw SJ, Plit M, Joubert JR on behalf of the Working Groups of SA Pulmonology Society.  Asthma in adults.  In: MIMS Disease Review 1995.  Eds. EJJ van der Horst, RJ van Rooyen, JR Snyman, de K Sommers.  Pretoria: MIMS (Division of Times Media) 1995, 693-711.

Bateman ED.  Pneumonia.  In: MIMS Disease Review 1995.  Eds JJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers.  Pretoria: MIMS (Division of Times Media).  1995, 721-728.

Bateman ED, Louw SJ, Plit M, Joubert JR.  Guidelines for the management of asthma in adults in South Africa.  In: The ALLSA Handbook of Practical Allergy.  Eds.  PC Potter and S Lee.  Eppindust: Credo Press 1994; 96-120.


Ainslie GM, Bateman ED.  Immunological aspects of the host response to Mycobacterium tuberculosis infection.  In: A Century of Tuberculosis: South African Perspectives.  Eds H M Coovadia and SR Benatar.  Cape Town: Oxford University Press.  1991; 224-242.

Bateman ED.  Bronchoalveolar lavage - A window to the lung. In: Proceedings of the Advanced Course in Medicine.  The Faculty of Medicine.  The College of Medicine of South Africa.  Ed MJD Cassidy. Cape Town, South Africa; UCT Printing Department.  1991, 63-71.

Bateman ED.  The Respiratory Clinic 1965 to 1990.  The first 25 years, Cape Town: UCT Printing 1990.

Voigt MD, Bateman ED, Louw SJ, Kirsch RE.  The pulmonary circulation in liver disease.  In: Cardiovascular complications of liver disease.  Eds A Bomzon and LM Blendis.  Boca Raton: CRC press.  1990, 103-124.

Bateman ED, Forder AA.  Infectious Complications.  In: The Transplantation and Replacement of Thoracic Organs.  Eds DKC Cooper and D Novitzky.  Lancaster, England; Kluwer Academic Press.  1990; 265-302.

Bateman ED.  Cellular responses and fibrogenesis.  In: Environmental Pollution and Man, International Symposium.  Editors, LR Heim, CDR Dunn, HM Garnett and P Jacobs.  Immunology and Haematology Research, Monograph 3 1984: 71-75.

Bateman ED, Forder AA.  Infectious Complications.  In: Heart transplantation.  The present status of orthotopic and heterotopic heart transplantation.  Eds, DKC Cooper and RP Lanza.  Lancaster: MTP Press, 1984; 195-222.
 
Benatar SR, Bateman ED.  Asbestos-Induced Lung Disease.  In: Recent Advances in Respiratory Medicine.  Ed D Flenley.  Edinburgh: Churchill Livingstone, 1983; 35-47.
 
Bateman ED, Burrell R.  Rapporteur’s Report.  In: Second Lung Toxicity Workshop.  Ed R Rylander.  Kungalu, Gotab,1981, 1981; 4-9.


Bateman ED, Emerson R, Cole P.  Mechanisms of Fibrogenesis.  In: Occupational Lung Diseases; Research Approaches and Methods.  Editor, H Weill and M Turner-Warwick, Lung Biology in Health and Disease.  Ed C Lenfant, New York, Marcel Dekker, 1981; 18:237-290.

Bateman ED, Emerson R, Cole P.  The use of diffusion chambers to examine the biological effects of mineral dusts.  In: The in vitro Effects of Mineral Dusts. Ed R C Brown et al. London, Academic 1980; 289-296. 
PAPERS IN PEER-REVIEWED JOURNALS 
2012  
Dawson R, Rom WN , Dheda K, Bateman ED. The new epidemic of non- communicable disease in people living with HIV. Public Health Action. 2012
 
Bousquet J, Schunemann JK, Somolinski B et al. Allergic Rhinitis and its Impact on Asthma: Achievements in 10 years and Future Needs. J Allergy Clin Immunol 2012; in press.
 
Vogelmeier C, Bateman ED, Pallante J, Vijay KT, Alagappan VKT, D’Andrea P, Chen, H, Banerji E. Once-daily QVA149 significantly improves lung function compared with twice-daily
salmeterol/fluticasone in patients with COPD: the ILLUMINATE study Lancet Respiratory Medicine, 2012, in press.
 
Bleecker ER, Bateman ED, Busse WW, Woodcock A, Frith L, House KW, Jacques L, Davis AM, Haumann B, Lotvall J. Once-daily fluticasone furoate is efficacious in patients with symptomatic
asthma on low-dose inhaled corticosteroids. Ann Allergy Asthma Immunol 2012;109:353-358.
 
Kerstjens HAM, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED. Tiotropium in asthma not controlled with inhaled
glucocorticosteroids and LABA. N Engl J Med 2012;367:1198-1207.
 
Fairall L, Bachmann MO, Lombard C, Timmerman V, Uebel K, Zwarenstein M, Boulle A, Georgeu D, Colvin CJ, Lewin S, Faris G, Cornick R, Draper B, Tshabalala M, Kotze E, van Vuuren C, Steyn D, Chapman R, Bateman ED. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet 2012, August http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60730-2/fulltext

Georgeu D, Colvin CJ, Lewin S, Fairall L, Bachmann MO, Uebel K, Zwarenstein M, Draper B, Bateman ED. Implementing nurse-initiated and managed antiretroviral treatment (NIMART)
in South Africa: a qualitative process evaluation of the STRETCH trial. Implementation Science 2012;7:66.
 
Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC, Studnicka M, Mejza F, Gillespie S, Vollmer WM  for the BOLD Collaborative Research Group. Case-finding options for COPD: Results from the BOLD Study. Eur Respir J, 2012, in press.
 
Lotvall J, Bateman ED, Bleecker ER, Busse WW, Woodcock A, Follows R, Lim J, Stone S, Jacques L. 24h duration of the novel LABA vilanterol trifenatate in asthma patients treated with ICS. Eur Respir J, 2012, Feb 23. [Epub ahead of print]
 
Boulet L-P, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, Bateman ED. A guide to the translation of Asthma Guidelines into improved care. Eur Respir J. 2012 May;39(5):1220-1229.
 
Bateman ED, Bleecker ER, Lötvall, Woodcock A, Forth R, Medley H, Davis AM, Jacques L, Haumann B, Busse WW. Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial. Respir Med. 2012 May;106(5):642-50. Epub 2012 Feb 18.
 
Bateman ED, Feldman G, Kilbride S, Brooks J, Mehta R, Harris S, Maden C, Crater G. Efficacy and safety of the long-acting muscarinic antagonist, GSK233705, delivered once-daily in patients with COPD. Clinical Respiratory Journal 2012, in press

Bousquet J, Anto JM, Demoly P, et al. in collaboration with the WHO Collaborating Center for Asthma and Rhinitis. Severe chronic allergic (and related) diseases: a uniform approach – a MeDALL-GA2LEN-ARIA Position Paper. Int Arch Allergy Immunol. 2012 Mar 1;158(3):216-231.

Jones PW, Singh D, Bateman ED, Agusti A, Lamarca R, de Miquel G, SegarraR, Caracta C, Garcia Gil E.  Efficacy and safety of twice-daily aclidinium bromide in COPD patients: The ATTAIN study. Eur Respir J 2012, 30 March, ePub ahead of print.

To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P. Global Asthma Prevalence in Adults: Findings from the Cross-Sectional World Health Survey. BMC Public Health, 2012 Mar 19;12(1):204.

Mahler EA, D”Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B; on behalf of the INTRUST-1 and INTRUST-2 study investigators. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax. 2012 Apr 27. [Epub ahead of print]

2011

  1. Pedersen SE, Hurd SS, Lemanske RF Jr, Becker A, Zar HJ, Sly PD, Soto-Quiroz M, Wong G, Bateman ED. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol. 2011; 46: 1-17.
  2. D.I. Ling, M. Pai, V. Davids, L. Brunet, L. Lenders, R. Meldau, G. Calligaro, B. Allwood, R. van Zyl-Smit, J. Peter, E. Bateman, R. Dawson, and K. Dheda. Are interferon-{gamma} release assays useful for active tuberculosis in a high-burden setting? Eur. Respir. J. published 24 February 2011, 10.1183/09031936.00181610
     
  3. Segal LM, Methe BA, Nolan A, Hoshino Y, Rom WM, Dawson R, Bateman E, Weiden MD. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thoracic Soc 2011;8:282-28.. DOI:10.1513/pats.201006-044WR.

    Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Östlund O, Byrne PM, Sears MR. S Eriksson GS. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011; 12: 38.

Schull MJ, Cornick R, Thompson S, Faris G, Fairall L, Burciul B, Sodhi S, Draper B, Joshua M, Mondiwa M, Banda H, Kathyola D, Bateman E, Zwarenstein M. From PALSA PLUS to PALM PLUS: adapting and developing a South African guideline and training intervention to better integrate HIV/AIDS care with primary care in rural health centers in Malawi. Implementation Science 2011; 6: 82.

Uebel K, Fairall LR, van Rensberg D, Bateman ED, Streamlining tasks and roles to expand treatment and care for HIV (STRETCH) trial: the development and implementation of an intervention to improve access to antiretroviral treatment in South Africa. Implementation Science. 2011,6:86. PMID:21810242.

 
Jones PW, Rennard SI, Agusti A, Chanez P, Magnussen H, Fabbri L, Donohue JF, Bateman ED, Gross NJ, Lamarca R, Caracta C, Garcia Gil E. Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease. Respiratory Research 2011;12:55

Zwarenstein M, Fairall LR, Lombard C, Mayers P, Bheekie A, English RG, Lewin S, Bachmann MO, Bateman ED. Outreach education integrates HIV/AIDS/ART in South African primary care clinics: a pragmatic cluster randomized trial. BMJ 2011 Apr 21:342:d2022. PMID:21511783.

Reddel H, Jenkins C, Quirce S, Sears MR, Bateman ED, O’Byrne PM, Humbert M, Buhl R, Harrison T, Brusselle GG, Thorén A, Sjöbring U, Peterson S, Östlund O, Eriksson GS. Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J 2011;38(3):584-593. PMID:21406510  

Bateman ED, Rabe KF, Calverley PMF, Goehring UM, Brose M, Bredenbröker D,  Fabbri L. Roflumilast with long-acting β2 agonists for COPD: influence of exacerbation history. Eur Respir J 2011 Sept:38(3):533-560. PMID: 21737553

Busse WW, Bleecker ER, Bateman ED, Lötvall J, Forth R, Davis AM, Jacques L, Haumann B, Woodcock A. Fluticasone furoate demonstrates efficacy in asthma patients symptomatic on medium doses of inhaled corticosteroid therapy: and 8-week randomized, placebo-controlled trial. Thorax 2011, Aug 9. PMID:21828231.

FitzGerald JM, Bateman E, Hurd S, Boulet L-P, Haahtela T, Cruz AA, Levy ML. The GINA Asthma Challenge: Reducing asthma hospitalizations. Eur Respir J, 2011;38:1.

Bateman ED
, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B!^-Arg/Arg patients with asthma. J Allergy Clin Immunol. 2011 Aug:128(2):315-322. PMID:21807250.

Woodcock A, Bateman ED, Busse WW, Lötvall J, Snowise NG, Forth R, Jacques L, Haumann B, Bleecker ER. Efficacy in asthma of once-daily treatment with fluticasone furoate: A randomized, placebo-controlled trial. Respiratory Research 2011, 12:132  doi:10.1186/1465-9921-12-132

Woodcock A, Bleecker ER, Bateman ED, Busse WW, Lötvall J, Snowise NG, Frith L, Jacques L, Haumann B, Fluticasone furoate: Once-daily evening treatment versus twice-daily treatment in moderate asthma. Respiratory Research 2011,12: 160.

Van Zyl-Smit RN, Binder A, Meldau R, Mishra, H, Semple PL, Theron G, Peter J, Whitelaw A, Sharma SK, Warren R, Bateman ED, Dheda K. Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS One 2011; 6(12): e228815.doi:10.1371/journal.pone.0028815.

Sodhi S, Banda H, Kathyola D, Burciul B, Thompson S, Joshua M, Bateman E, Fairall L, Martinuik A, Cornick R, Faris G, Draper B, Mondiwa M, Katengeza E, Samuch L, Schull M. Evaluating a streamlined clinical tool and educational outreach intervention for health care workers in Malawi: The PALM PLUS case study. BMC International Health and Human Rights 2011;11(Suppl 2): 511.

Hodder R, Pavia D, Lee A, Bateman ED. Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft MistTM Inhaler in COPD. International Journal of COPD. 2011;6: 245-251.
 
Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA, and for the BOLD Collaborative Research Group. COPD in Never Smokers. Results from the Population-Based Burden of Obstructive Lung Disease Study. Chest 2011;139(4):752-763.
2010

van Zyl Smit RN, Pai M, Yew WW, Leung C, Zumla A, Bateman ED, Dheda K. Global Lung Health: The Colliding Epidemics of Tuberculosis, Tobacco Smoking, HIV and COPD. Eur Respir J 2010;35:27-33.

Fairall L, Bachmann MO, Zwarenstein M, Bateman ED, Niessen LW, Lombard C, Majara B, English R, Bheekie A, van Rensburg D, Mayers P, Peters A, Chapman R. Cost effectiveness of educational outreach to primary care nurses to increase tuberculosis case detection and improve respiratory care: economic evaluation alongside a randomised trial. Tropical Medicine & International Health 2010;15:277-86.

  1. Bachmann MO, Fairall LR, Lombard C, Timmerman V, van der Merwe S, Bateman ED, Zwarenstein M. Effects on tuberculosis outcomes of educational outreach to South African clinics during two randomised trials. Int J Tuberc Lung Dis 2010;14:311-317.
  2. Cruz AA, Bateman ED, Bousquet J. The social determinants of asthma. Eur Respir J 2010;35:239-42.
  3. Dawson R, Masuka P, Edwards DJ, Bateman E, Bekker LG, Wood R, Lawn SD. Chest radiographic reading and recording system (CRRS): evaluation for TB screening in advanced HIV patients. Int J Tuberc Lung Dis 2010; 14: 52-58.
  4. Dekhuijzen PNR, Kneussl M, Bateman ED, Partridge MR, Lavorini F, Virchow JC, Stowasser S, Steinkamp G. Managing asthma in real life: What really matters? Ann  Respir Med, 2010;1:3-10.
  5. O’Byrne P, Reddel HK, Eriksson G, Östlund, O, Peterson, S, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, Bateman ED. Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010;36:269-276. doi:10.1183/09031936.00124009
  6. Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O. Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, O’Byrne PM. Overall asthma control: The relationship between current control and future risk. J Allergy Clin Immunol 2010; doi:10.10.16/j.jaci2009.11.033. PMID: 20153029
  7. Colvin CJ, Fairall L, Lewin S, Georgeu D, , Zwarenstein M, Bachmann M, Uebel K, Bateman ED. Expanding access to ART in South Africa: The role of nurse-initiated treatment. S Afr Med J 2010; 100:210-212. PMID: 20459957
  8. Bateman ED, Singh D, Smith D, Disse B, Towse L, Massey D, Blatchford J, Pavia D, Hodder R. Efficacy and safety of Tiotropium Respimat® SMI in COPD in two 1-year randomized studies. Internat J COPD, 2010, 5; 197-208.
  9. Bousquet J, Kiley J, Bateman ED, Viegi G, Khaltaev N, Cruse AA. Prioritized agenda for Prevention and Control of Chronic Respiratory Diseases. Eur Respir J 2010, 36:995-1001. PMID: 20223919
  10. Bateman ED, Tashkin D, Siafakas N, Dahl R, Towse L, Massey D, Pavia D, Zhong NS. A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients. Respir Med 2010;104: 1460-72. PMID: 20620037
  11. Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Respir Med. 2010 Aug;104(8):1179-88. PMID: 20172704
  12. Bousquet J, Schünemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, Canonica GW, Casale TB, Demoly P, Gerth van Wijk R, Ohta K, Bateman ED, Calderon M, Cruz AA, Dolen WK, Haughney J, Lockey RF, Lotvall J, O’Byrne P, Spranger O, Togias A, Bonini S, Boulet LP, Camargos P, Carlsen KH, et al. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy 2010,65:1212-21. PMID: 20887423
  13. Schull MJ, Banda H, Kathyola D, Fairall L, Martiniuk A, Burciul B, Zwarenstein M, Sodhi S, Thompson S, Joshua M, Mondiwa M, Bateman ED. Strengthening health human resources and improving clinical outcomes through an integrated guideline and educational outreach in resource-poor settings: a cluster-randomized trial. Trials 2010, 11:118 Yorgancıoğlu A, Yardım N, Ergün P, Karlıkaya C, Kocabaş A, Mungan D, Yıldız F, Akdağ R, Keskinkılıç B, Karakoç GB, Köktürk N, Ozacar R, Saçkesen C, Yüksel H,

  14. Akçay S, Altan P, Altunsu T, Arpacı N, Aytaç B, Cakır B, Coban SC, Göktaş E, Gündoğan A, Kakillioğlu T, Kosdak M, Tugay D, Khaltaev N, Cruz A, Bateman E, Baena CC, Dahl R, Bousquet J. Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey. Tuberk Toraks 2010;58(2):213-28. Review. PMID:20865577
  15. 2009
  16. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, Symons G, Khalfey H, Carr I, Maredza A,  Dawson R, Wainwright H, Whitelaw A, Bateman E, Zumla A.. Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting. PLoS ONE 2009:34:1-9.
  17. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Bateman ED, and Dheda K. Within-subject Variability and Boosting of T Cell Interferon-γ Responses after Tuberculin Skin Testing . Am. J. Respir. Crit. Care Med. 2009; 180:49-58.
  18. .
  19. Bateman ED, Feldman C, Mash R, Fairall LR, English RG, Jithoo A. Systems for the management of respiratory disease in primary care - an international series: South Africa. Prim Care Respir J. 2009; 18: 69-75.
  20. Dheda K, van Zyl-Smit RN, Sechi LA, Badri M, Meldau R, Meldau S, Symons G, Semple L, Maredza A, Dawson R, Wainright H, Whitelaw A, Vallie Y, Raubenheimer P, Bateman ED, Zumla A. Utility of quantitative T cell responses versus unstimulated IFN-{gamma} for the diagnosis of pleural tuberculosis. Eur Respir J 2009;34:1118-26.
  21. Dheda K,  van Zyl Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, Govender N, Rosu V, Sechi LA, Marezda A, Semple PL, Whitelaw A, Wainright H, Badri M, Dawson R, Bateman ED, Zumla A. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 2009;64:847-53.
  22. Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HAM, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE on behalf of the American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations. Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Amer J Resp Crit Care Med 2009;180:59-99.
  23. Bateman ED, Rennard SI, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, Nadel JA, Pfeifer M, Racké K, Rabe KF, Rubin BK, Welte T, Wessler I. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009;22:533-42.
  24. Baatjies R, Lopata AL, Sander I, Raulf-Heimsoth M, Bateman ED, Meijster T, Heederik D, Robins TG, Jeebhay MF. Determinants of asthma phenotypes in supermarket bakery workers. Eur Respir J 2009;34:8245-33.
  25. Dawson R, Condos R, Tse D, Huie ML, Ress S, Tseng CH, Brauns C, Weiden M, Hoshino Y, Bateman E, Rom WN. Immunomodulation with recombinant interferon-gamma 1b in pulmonary tuberculosis. Plos One 2009; 15:4:e6984.
  26. Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, Zuberbier T; Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124:428-33.
  27. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF; M2-127 and M2-128 study groups. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009;374:695-703.
  28. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009;374(9691):685-94.
  29. Yorgancioğlu A, Türktaş H, Kalayci O, Yardim N, Buzgan T, Kocabaş A, Karlikaya C, Yildiz F, Ergün P, Mungan D, Kart L, Göktaş E, Musaonbaşioğlu S, Gündoğan A, Akdağ R, Akçay S, Akin M, Akkurt I, Altan P, Altunsu T, Arpaci N, Aydin C, Aydin S, Aydinli F, Aytaç B, Bavbek S, Biber C, Bingöl Karakoç G, Ceyhun G, Cakir B, Celik G, Cetinkaya T, Ciçek ME, Coban SC, Cobanoğlu N, Com S, Cöplü L, Demirkazik A, Doğan E, Ekmekçi EB, Elbir M, Erdoğan A, Ergüder T, Gemicioğlu B, Gögen S, Gülbahar O, Güngör H, Horzum E, Içer Y, Imamecioğlu AR, Kahraman N, Kakillioğlu T, Kalyoncu F, Karakaya M, Karakaya G, Karaodul G, Kesici C, Keskinkiliç B, Kilinç O, Kirmizitaş F, Kosdak M, Köktürk N, Metintaş M, Numanoğlu SC, Gümrükçüoğlu OF, Onal Z, Onal B, Ozacar R, Ozen HA, Ozkan S, Oztürk F, Polat H, Saçkesen C, Selçuk T, Serin G, Sönmez G, Sahin M, Sahinöz S, Sahinöz T, Simşek B, Tartan N, Toprak A, Tugay T, Tuncer A, Uçan ES, Unüvar N, Yapicikardeşler B, Yildirim N, Yol S, Yüksel H, Khaltaev N, Cruz A, Minelli E, Bateman E, Baena Cagnani C, Dahl R, Bousquet J. Tuberk Toraks. The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). Tuberk Toraks 2009;57(4):439-52. Review. PMID: 20037863.
2008 
Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E. A randomised study of tiotropium Respimat® Soft Mist™ Inhaler versus ipratropium pMDI in COPD. Respir Med 2008; 102: 32-41.
 
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global Strategy for Asthma Management and Prevention: GINA Executive Summary. Eur Respir J, 2008; 31: 1-36. PMID: 18166595

Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstatter R. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.  Pulm Pharmacol Ther 2008; 21:264-75.  doi:10.1016/j.pupt.2007.05.002  
 
Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, Staniland GH, Timmerman V, Msimanga M, Seebregts CJ, Boulle A, Nhiwatiwa R,  Bateman ED, Zwarenstein MF. Effectiveness of antiretroviral treatment in a South African program: cohort study. Archives Internal Medicine 2008; 168:86-93.
 
Den Boon S, Verver S, Lombard CJ, Bateman ED, Irusen EM, Enarson DA, Borgdorff MW, Beyers N. Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect 2008;136:1342-9. Epub 2008 Jan 4. PMID: 18177518
 
Fairall LR, Bachmann MO, Zwarenstein MF, Lombard CJ, Uebel K, van Vuuren C, Steyn D, Boulle A, Bateman ED. Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol. Trials 2008; 9:21
 
Bateman ED, Nelson H, Bousquet J, Kral K, Sutton L, Ortega H, Yancey S. Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann

Intern Med 2008;149: 33-42.  
Bateman ED, Bousquet J, Busse WW, Clark TJH, Gul N, Gibbs M, Pedersen S on behalf of the GOAL Steering Committee and Investigators. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy 2008; 63: 932-8.
 
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63 Suppl 86:8-160.
 
Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U; Guideline Committee of 1999, Klugman K, Phillips D, Cameron NA, Eggers RR. Influenza guideline for South Africa – update 2008. S Afr Med J 2008; 98: 224-30.

 English RG, Bateman ED, Zwarenstein MF, Fairall LR, Bheekie A, Bachmann MO, Majara B, Ottmani S-E, Scherpbier RW. Development of a South African integrated syndromic respiratory disease guideline for primary care. Primary Care Respiratory Journal 2008;17;156-63.
 
van Weel C, Bateman ED, Bousquet J, Reid J, Grouse L, Schermer T, Valovirta E, Zhong N. Asthma management pocket reference 2008. Allergy 2008;63:997-1—4.

 Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL,  Gibson PG, de Jongste JC, Kerstjens  HAM, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD, Thomas MD, Wenzel SE, Reddel HK. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32:545-54.  

Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, O’Byrne PM; START Investigators Group. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008;121:167-74.

 Jeebhay MF, Robins TG, Miller ME, Bateman ED, Smuts M, Baatjies R, Lopata AL. Occupational allergy and asthma among salt water fish processing workers. Amer J Indust Med 2008;51:899-910.  

Stein J, Lewin S, Fairall L, Mayers P, English R, Bheekie A, Bateman E, Zwarenstein M. Building capacity for antiretroviral delivery in South Africa: A qualitative evaluation of the PALSA PLUS nurse training programme. BMC Health Serv Res 2008, 8:240. [Epub ahead of print] PMID:19017394.
 
Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjobe S, Decramer M UPLIFT Study Investigators. N Engl J Med 2008; 359:1543-54. 
 
Greening AP, Stempel D, Bateman ED, Virchow JC. Managing asthma patients: which outcomes matter? Eur Respir Rev 2008;17:53-61.

Chylack LT Jr, Gross GN, Pedinoff A: Ciclesonide Lenticular Safety Study Group. A randomised, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity. J Asthma 2008; 45:893-902.
 
Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U; Guideline Committee of 1999, Klugman K, Phillips D, Cameron NA, Eggers RR. Influenza guideline for South Africa – update 2008. S Afr Med J 2008;98:224-30.

2007   Green RJ, Zar HR,

Bateman ED
. Asthma: Is survival good enough? S Afr Med J 2007; 97:172-174.  

Bateman ED
, Jithoo A. Asthma and Allergy - A Global Perspective. Allergy 2007; 62:213-215.  

Bateman ED, Bousquet J, Busse WW, Clark TJH, Pedersen SE on behalf of the GOAL Investigators Group. The correlation between asthma control and health status: the GOAL study.  European Respiratory Journal, 2007;29:56-62.   English RG, Fairall L,

Bateman ED.
Keeping Allergy on the Agenda: Integrated guidelines for respiratory disease in developing countries. Allergy 2007;62:224-229.   Spencer S, Mayer B, Bendall KL,

Bateman ED
. Validation of a guideline-based composite outcome assessment tool for asthma control. Respiratory Research 2007;8:26   doi:10.1186/1465-9921-8-26.   Den Boon S, Verver S, Marais BJ, Enarson DA, Lombard CJ,

Bateman ED
, Irusen E, Jithoo A, Gie RP, Borgdorff MW, Beyers N. Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 2007; 119:734-739.   Boulet L-P,

Bateman ED
, Voves R, Müller T, Wolf S, Engelstätter R. A randomised study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. Respiratory Medicine 2007; 101: 1677-86.   Woodcock AA, Bagdonas A, Boonsawat W, Gibbs MR, Bousquet J,

Bateman ED on behalf of the GOAL Steering Committee & Investigators. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate and fluticasone propionate alone. Primary Care Respiratory Journal 2007;16:155-61.  

Bateman ED, Clark TJH, Frith L, Bousquet J, Busse WW, Pedersen SE for the GOAL Investigators Group. Rate of response of individual asthma control measures varies and may overestimate asthma control. J Asthma 2007, 44:667-73.   den Boon S, van Lill SW, Borgdorff MW, Enarson DA, Verwer S,

Bateman ED
, Irusen E, Lombard CJ, White NW, de Villiers C, Beyers N. High prevalence of previously treated tuberculosis among undetected cases of tuberculosis, Cape Town, South Africa. Emerg Infect Dis 2007; 13: 1189-94.   Pedersen SE,

Bateman ED
, Bousquet J, Busse WW, Yoxall S, Clark TJ, Gaining Optimal Asthma controL Steering Committee and Investigators. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma ControL study. J Allergy Clin Immunol 2007; 120: 1036-42.   Barnes NC, Jacques L, Goldfrad C,

Bateman ED
. Initiation of maintenance treatment with salmeterol/ fluticasone propionate 50/100µg bd versus fluticasone propionate 100µg bd alone in patients with persistent asthma: Integrated analysis of four randomized trials. Respir Med 2007; 101: 2358-65.  

Bateman ED, Cheung D, Lapa e Silva J, Guhring UMG, Schaefer M, Engelstatter R. Randomized comparison of ciclesonide 160μg/day and 640μg/day in severe asthma. Pulm Pharmacol Ther 2007, Epub ahead of print: http://dx.doi.org/10.1016/j.pupt.2007.11.002   Feldman C, Brink AJ, Richards GA, Maartens G, Bateman ED, for working group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J, 2007; 97: 1295-1306. 

Obihara CC, Kimpen JLL, Gie RP, van Lill SW, Hoekstra MO, Marais BJ, Schaaf HS, Lawrence K, Potter PC, Bateman ED, Lombard CJ, Beyers N. Mycobacterium tuberculosis infection may protect against allergy in a tuberculosis endemic area. Clinical Experimental Allergy 2006,36:70-76.  

Bateman ED
, Izquierdo JL,  Harnest U, Hofbauer P, Magyar P, Schmid-Wirlitsch C, Leichtl S, Bredenbröker D. Efficacy and safety of roflumilast in the treatment of asthma. Annals of
Allergy Asthma Immunology 2006;96:679-86.
 
Bateman ED, Jacques L, Goldfrad C, Atienza T, Mihaescu T, Duggan M. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. Journal of Allergy Clinical Immunology 2006;117,563-70.
 
Bateman ED, Fairall L, Lombardi DM, English R. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respiratory Research 2006;7:13.
 
Juniper EF, Bousquet J, Abetz L, Bateman ED and the GOAL Committee.  Identifying “Well-controlled” and Not Well-controlled” asthma using the Asthma Control Questionnaire. Respiratory Medicine 2006; 100:616-21.
 
Bateman ED. Severity and control of severe asthma. Editorial. Journal of Allergy and Clinical Immunology 2006; 117:519-21.
 
Bateman ED, Karpel J, Casale T, Wenzel S, Banerji D. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma. Chest 2006; 129:1176-1187.
 
Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJH, Pedersen SE, Bateman ED, on behalf of the GOAL Investigators Group. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006;61:531-6.
 
Ericsson K, Bantje TA, Huber RM, Borg S, Bateman ED. Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate persistent asthma. Respiratory Medicine 2006; 586-94.
 
Rennard SI, Calverley P, Bateman ED.  Chronic Obstructive Pulmonary Disease: Linking Outcomes and Pathobiology of Disease Modification. Introduction. Proceedings of the American Thoracic Society 2006;3:211.
 
Bateman ED. The economic burden of uncontrolled asthma across Europe and the Asia Pacific region: can we afford to not control asthma? European Respiratory Review 2006; 15: 1-3.

 English RG, Bachmann M, Bateman ED, Zwarenstein M, Fairall L, Bheekie A, Lombard. Diagnostic accuracy of an integrated respiratory guideline in identifying patients with respiratory
symptoms requiring screening for pulmonary tuberculosis: a cross-sectional study. BMC Pulmonary Medicine 2006, 6:22.
 
J COPD Editors and Editorial Board. The Burden of Tobacco on Life and Health and the Voice of the Journal of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 2006; 3: 123-4.
 
Poikiloderma, tendon contracture, and pulmonary fibrosis: a new autosomal dominant syndrome. Khumalo NP, Pillay K, Beighton P, Wainwright H, Walker B, Saxe N, Mayosi BM, Bateman ED. British Journal of Dermatology 2006; 155:1057-61.
 
Bateman ED, van Dyk M, Sagriotis A. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study. Pulm Pharmacol Ther 2006; 21: 22-25.  http://dx.doi:10.1016/j.pupt.2006.10.001.
 
Bheekie A, Buskens I, Allen S, English R, Mayers P, Fairall L, Majara B, Bateman ED, Zwarenstein M, Bachmann M. The Practical Approach to Lung Health in South Africa PALSA) intervention: respiratory guideline implementation for nurse trainers. Int Nurs Rev 2006; 53: 261-268.
 
den Boon S, White NW, van Lill SWR, Borgdorff MW, Verver S, Lombard CJ, Bateman ED, Irusen E, Enarson DA, Beyers N. An evaluation of symptom and chest radiographic screening in tuberculous prevalence studies. Int J Tuberc Lung Dis 2006; 10: 876-882.

O’Byrne PM,  Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. American Journal of Respiratory and Critical Care Medicine 2005; 171: 129-136.
 
Rabe KF, Bateman ED, O’Donnell D, Witte S, Bredenbröker D, Bethke TD. Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2005, 366: 563-571.
 
Obihara CC, Marais BJ, Gie RP, Potter P, Bateman ED, Lombard CJ, Beyers N, Kimpen JL. The association of prolonged breastfeeding and allergic disease in poor urban children. European Respiratory Journal 2005; 25: 970-977.
 
Den Boon S, van Lill SWP, Borgdorff MW, Verver S, Bateman ED, Lombard CJ, Enarson DA, Beyers N. The association  between smoking and tuberculosis infection: A population survey in a high tuberculosis incidence area. Thorax 2005, 60: 555-557.
 
Den Boon S, Bateman ED, Enarson DA, Borgdorff MW, Verver S, Lombard CJ, Irusen E, Beyers N, White NW. Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. International Journal of Tuberculosis and Lung Disease 2005; 9: 1-9.
 
Fairall LR, Zwarenstein M, Bateman ED, Bachmann M, Lombard C, Majara BP, Joubert G, English RG, Bheekie A, van Rensburg D, Mayers P, Peters AC, Chapman RD. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. British Medical Journal 2005;331:750-754.
 
Bateman ED. Introduction. Improving inhaler use in COPD and the role of patient preference. European Respiratory Review 2005; 14: 83-84.
 
Bateman ED. Improving inhaler use in COPD and the role of patient preference. European Respiratory Review 2005;14:85-88.
 
Marais BJ, Obihara CC, Gie RP, Schaaf HS, Hesseling AC, Lombard C, Enarson D, Bateman E, Beyers N. The prevalence of symptoms associated with pulmonary tuberculosis in randomly selected children from a high burden community. Archives of Diseases of Children 2005; 90:1166-1170.
 
Aziz ZA, Wells AU, Bateman ED, Copley SJ, Desai SR, Grutters JC, Milne DG, Phillips GD, Smallwood D, Wiggins J, Wilsher ML, Hansell DM. Interstitial Lung Disease: Effects of Thin-Section CT on Clinical Decision Making. Radiology 2005; 238:725-733.

2004  
Bateman ED, Feldman C, O’Brien J,.Plit M, Joubert JR.  Guideline for the Management of Chronic Obstructive Pulmonary Disease (COPD):  2004 Revision.  South African Medical Journal 2004; 94: 559-575.
 
Kassner F, Hodder R, Bateman ED.  A Review of Ipratropium Bromide/Fenoterol Hydrobormide (Berodual ® Delivered Via Respimat ® Soft Mist™ Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease.  Drugs 2004; 64: 1671-1682.
 
bateman ED, Boushey H, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE for the Gaining Optimal Asthma Control Investigators Group. Can guideline-defined asthma control

be achieved? The Gaining Optimal Asthma Control Study. American Journal of Respiratory and Critical Care Medicine 2004; 170:836-844.

2003  
Ringdal N, Eliraz A, Pruzinec P, Weber H H, Mulder P G H, Akveld M, Bateman E D. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respiratory Medicine, 2003; 97: 234-241.
 
Bateman ED, Feldman C, O’Brien J, Plit M, Joubert JR.  Guidelines for the Management of Chronic Obstructive Pulmonary Disease (COPD):  2002 Revision. South African Respiratory Journal 2003; 9: S1-18.
 
Bateman E D,  Bantje TA, Gomes M J, Toumbis MG, Huber RM, Naya I, Eliraz A.  Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma. American Journal of Respiratory Medicine 2003:2(3):275-281.
2002
 
Travis WD, King TE, Bateman ED, Lynch DA for the Core Panel. ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS). American Journal of Respiratory and Critical Care Medicine 2002; 165: 277-304.
 
Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control – does the patient benefit?  European Respiratory Journal, 2002; 20:588-595.
 
Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ, Kesten S, Towse L. A 6-month placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.
 
Feldman C, Brink AJ, Richards G, Bateman ED, O’Brien J, Maartens G, Klugman KP.  Management of Community-Acquired Pneumonia in Adults - Clinical Guideline.  South African Medical Journal 2002; 92: 647-655.
 
Poyser MA, Nelson H, Ehrlich RI, Bateman ED, Parnell S, Puterman A, Weinberg E.  Socioeconomic deprivation and asthma prevalence and severity in young adolescents. European Respiratory Journal 2002; 19: 892-898.
 
White NW, Girdler-Brown BV, Feldman C, Bateman ED. Respiratory illness and pulmonology in South Africa - Distribution and trends 1987 - 1997. A report commissioned by the SA Thoracic Society. South African Respiratory Journal 2002; 7: 137-143.

2001  
Bateman ED, Silins V, Bogolubov M. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100Ug twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma. Respiratory Medicine 2001; 95: 136-146.
 
Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. European Respiratory Journal 2001; 17: 589-595.
 
Zar HJ, Hanslo D, Tannenbaum E, Klein M, Argent A, Eley B, Burgess J, Magnus K, Bateman ED, Hussey G. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatrica 2001: 90:119-125.
 
Zar HJ, Apolles P, Argent A, Klein M, Burgess B, Hanslo D, Bateman ED, Hussey G. The etiology and outcome of pneumonia in human immunodeficiency virus infected children admitted to intensive care in a developing country. Pediatric Critical Care Medicine 2001; 2:108-111.
 
Zar HJ, Stickells D, Toerien A, Wilson D, Klein M, Bateman ED. Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980 – 1997. European Respiratory Journal 2001; 18:33-37.
 
Bateman ED. Measuring asthma control. Current Opinion in Allergy and Clinical Immunology 2001; 1: 211-216.
 
Bateman ED. Using clinical measures of disease control to reduce the burden of asthma, Pharmacoeconomics 2001; 19 Suppl.2: 7-11.
 
Bousquet J, van Cauwenberge P, Khaltaev N, on behalf of an expert committee Allergic Rhinitis and its Impact on Asthma (ARIA).ARIA Workshop Report. Journal of Allergy and Clinical Immunology 2001; 108: S1-147.
 
2000 
Zar HJ, Bateman ED.  Near-fatal asthma – a review. South African Journal of Critical Care 2000; 16:5-9.
 
Lalloo UG, Bateman ED, Feldman C, Bardin PG, Plit M, Irusen EM, O’Brien J. Guidelines for the management of chronic asthma in adults  -  2000 Update. For the South African Pulmonology Society Adult Asthma Working Group. South African Medical Journal 2000; 90: 540-552.
 
Bateman ED, Adler L, Chyrek-Borowska S, Theman K, Rogeaux Y, Schultze-Werninghaus G, Nel AM, Pasquet J-P, Notelet D, Hardy P, Petillo J, Banerji D.  Inhaled Triamcinolone acetonide HFA 450μg twice daily compared with beclomethasone dipropionate CFC 500μg twice daily in adults with moderate persistent asthma. Clinical Drug Investigation 2000; 20:9-17.
 
1999
Onyebujoh PC, Levin JB, Fourie FB, Garhiram V, Tembe LC, Phili NP, Mthiyane TCP, Moniwa T, Bayer G, Ramajoe IM, Mncwabe TAB, Mallisar LGM, Saul TMN, Levin JB, Jackson THFG, Suparsad S, Fine PEM, Pendlebury DJS, Fine E, Houghton I, Clyde J, Vos HP, Padayatchi N, Pala A, Ramjee A, Ramjee M, Ramdeen J, Masters IH, Osbourne G, Naidu K, Bamba S, Mazur B, Czarnocki R, Landers K, Ndlovu G, Maphumulo N, Garhiram V, Sturm AW, Moodley J, Pillay C, Roux L, Moodley R, Sarawan A, Jali T, Manickam F, Smith A, Gopaul, Durosanmi T, Moonsammy R, Wyld P, McCallum J, Fulton C, Bisset K, Henderson S, Stewart D, Nticinka O, Watson D, Tuckwell N, Kennard D, Stanford JL, Rook GA, Grange JM, Zumla AA, Bateman ED, Hopewell P, Darbyshire J, Geiter L, Nunn A, Weyer K.  Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomized controlled trial. Lancet 1999; 354: 116-119.
 
Lewis SJ, Ainslie GM, Bateman ED. Efficacy of azathiaprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis 1999; 16: 87-92. Bateman ED. Salmeterol/fluticasone propionate combination. Guest commentary. Drugs 1999; 57: 941-943.
 
Bateman ED. Salmeterol/fluticasone propionate combination. Guest commentary. Drugs 1999; 57: 941-943.
 
1998 
Bateman ED, Britton M, Carrillo J, Almeida J, Wixon C.  Salmeterol/fluticasone combination inhaler.  A new, effective and well tolerated treatment for asthma.  Clinical Drug Investigation 1998; 16:193-201.
Zar H, Bateman ED.  New advances in cystic fibrosis - Implications for developing countries.  South African Medical Journal 1998; 88: 967-968.
 
O’Brien J, Feldman C, Bateman ED, Plit M, Guidelines for the management of chronic obstructive pulmonary disease.  For a Working Group of the South African Pulmonology Society.  South African Medical Journal 1998; 88: 999-1010.
 
1997 
Bateman ED.  ICU care for tuberculosis - fielding on the boundary.  Editorial . South African Medical Journal 1997; 87:635-7. 

1996
Feldman C, Gie R,  Bateman ED, Klugman KP, Richards G, Maartens G, Ras G.  Clinical Guidelines: Management of Community-acquired pneumonia.  South African Medical Journal 1996; 86:1152-1163.

Bateman ED.  Comment: Rehabilitation for the elderly with respiratory limitation. Journal of Age-Related Diseases 1996; 8: 4.

Bateman ED
, Stickells D, Goodman H.  The pathogenesis and radiological features of hut lung.  South African Journal of Radiology 1996; 1: 4-6.

1995

Ayres JG, Bateman ED, Lundback B, Harris TAJ.  High dose fluticasone propionate 1mg daily versus fluticasone propionate 2mg daily or budesonide 1.6mg daily in patients with chronic severe asthma.  European Respiratory Journal 1995, 8:579-586.
 
Bateman ED, Hayashi S, Kuwano K, Wilke TA, Hogg JC.  Latent adenoviral infection in follicular bronchiectasis.  American Journal of Respiratory and Critical Care Medicine 1995; 151:170-176.

Pillans PI, Tooke AFR, Bateman ED, Ainslie GM.  Acute polyarthritis associated with azathioprine for interstitial lung disease.  Respiratory Medicine 1995; 89:63-64.
 
Brice EAW, Friedlander W, Bateman ED, Kirsch RE.  Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 1995; 107:706-710.
 
1994 
Bateman ED.  A new look at the natural history of aspergillus hypersensitivity in asthmatics.  Editorial.  Respiratory Medicine, 1994; 88:325-327.
Pinkney-Atkinson V, Bateman ED, Rens H.  Managing mild to moderate chronic asthma - part 3.  Nursing RSA Verpleging 1994; 9:28-30.


Bateman ED, Plit M, Joubert JR.  Guidelines for the management of asthma in adults in South Africa: South African Medical Journal 1994; 84:332-338.
 
1993
Ford DK, Stein HB, Schulzer M, Bateman ED, Hogg JC, Hayashi S.  Lymphocytes from the site of disease suggest adenovirus is one cause of persistent or recurrent inflammation arthritis.  Journal of Rheumatology 1993; 20:310-3.

Bateman ED.  Diagnosis and management of pulmonary thromboembolism.  South African Journal of Continuing Medical Education 1993; 11; 2019-2036.

Bateman ED.  Is tuberculosis chemoprophylaxis necessary for patients receiving corticosteroids for respiratory disease?  Editorial. Respiratory Medicine 1993; 87:485-487.
 
1992
Louw SJ, Bateman ED, Plit M, Joubert J.  Guidelines for the management of asthma in adults in South Africa.  Part I. Chronic persistent asthma.  Statement by a working group of the South African Pulmonology Society.  South African Medical Journal 1992; 81:319-322.

Bateman ED.  Editorial.  Frequency of mutant cystic fibrosis genes in South Africa.  South African Medical Journal 1992; 82:2.

Ainslie GM, Solomon JA, Bateman ED.  Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery.  Thorax 1992; 47:513-518.

Gordon PC, Bateman ED, Linton DM.  Bilateral phrenic nerve palsy following cardiac surgery in a diabetic patient.  Anaesthesia and Intensive Care 1992; 20:511-514. 

1991 
Bateman ED.  Narrowing the gap in clinical spirometry.  S Afr Med J 1991; 79:357-8.
White NW, Chetty R, Bateman ED. Silicosis among gemstone workers in South  Africa: Tiger’s-eye silicosis.  American Journal of Industrial Medicine 1991; 19:205-213.

Bateman ED
.  An approach to the chronic cough.  South African Journal of Continuing Medical Education 1991; 9:401-408.

Maartens G, Bateman ED.  Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase.  Thorax 1991; 46:96-99.

Grobbelaar JP, Bateman ED.  Hut lung-a domestically acquired pneumoconiosis of mixed aetiology in rural women.  Thorax 1991; 46:334-340.
 
1990 
Bateman ED, Ainslie GM.  Bronchoalveolar lavage - A window to the lung.  Editorial.  South African Medical Journal 1990; 77:550-552.

Hammond JMJ, Bateman ED.  Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus.  Respiratory Medicine 1990; 84:77-90.

Bateman ED
, Morrison SC.  Catamenial haemoptysis from endobronchial endometriosis - a case report and review of previously reported cases.  Respir Med 1990; 84:157-161.

Bateman ED.  Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis: Two stages of the same disorder.  Current Allergy 1990; 3:7-11.

Willcox PA, Bateman ED, Potgieter PD, Benatar SR.  Experience with fibreoptic bronchoscopy in the diagnosis of pulmonary shadows in renal transplant recipients over a 12 year period.  Respiratory Medicine 1990; 84:297-302.

Bateman ED.  Lung Medicine in the 1990's.  Editorial.  South African Medical Journal 1990; 78:707-708.

White NW, Raine RI, Bateman ED.  Asthma and hyperthyroidism.  South African Medical Journal 1990; 78:750-752.

Chapman PJ, Bateman ED, Benatar SR.  Primary pulmonary hypertension and thromboembolic pulmonary hypertension-similarities and differences.  Respiratory Medicine 1990; 84:485-488.

Chapman PJ, Bateman ED, Benatar SR.  Prognostic and therapeutic considerations in clinical pulmonary hypertension.  Respiratory Medicine 1990; 84:489-494.
 
Van Zyl AI, Jennings AA, Bateman ED, Opie LH.  A comparison of the respiratory effects of two cardioselective betablockers, celiprolol and atenolol in asthmatics with mild to moderate hypertension.  Chest 1989; 95:209-213
 
Bateman ED.  Acute respiratory distress - diagnosis and management.  Trauma 1988; 5:2-19.

Goldin JG, Bateman ED.  Does nedocromil sodium have a steroid-sparing effect in adult asthmatic patients requiring maintenance oral steroids?  Thorax 1988; 43:982-986.
 
Bateman ED, Louw SJ, Bowey FSB, Joubert JR, Rees D, Zwi S, Mets JT.  Occupational asthma - time for scheduling as a compensable disease.  South African Medical Journal 1988; 74:545-546.

Bateman ED, Benatar SR.  Asbestos-induced diseases, clinical perspectives.  Quarterly Journal of Medicine 1987; 62: 183-194.

Findley I, Linton DM, Bateman ED, de Villiers JC.  Unilateral pulmonary oedema.  South African Journal of Critical Care 1987; 2:31-34
 
Klech H Haslam P, Turner Warwick M et al.  World-wide clinical survey on bronchoalveolar lavage (BAL) in sarcoidosis.  Experience in 62 centres in 19 countries.  Preliminary analysis.  Sarcoidosis 1986; 3: 113-122.

Willcox PA, Potgieter PD, Bateman ED, Benatar SR.  Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscopy.  Thorax 1986; 41:681-684.
 
Benatar SR, Bateman ED, Ainslie GM.  Progress in understanding sarcoidosis.  Editorial.  South African Medical Journal 1985; 67:73-75.
 
Bateman ED.  Terminology of interstitial lung disease.  Editorial.  South African Medical Journal 1984; 65: 190-191.
Louw
SJ, Bateman ED, Benatar SR. Cryptogenic fibrosing alveolitis: Clinical spectrum and treatment. South African Medical Journal 1984; 65: 195-200.

Kirk JME, Bateman ED, Haslam PL, Laurent JL, Turner-Warwick M. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.  Thorax 1984; 39:726-732.

Bateman ED, Turner-Warwick M, Haslam P, Adelman-Grill BC.  Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.  Thorax 1983; 38: 93-101.

Peters EM, Bateman ED.  Ultra-marathon running and upper respiratory tract infections - an epidemiological survey. South African Medical Journal 1983; 64:582-584.
 
Cohen RD, Bateman ED, Potgieter PD. Near-fatal bronchospasm in an asthmatic patient following ingestion of flurbiprofen.  South African Medical Journal 1982; 61:803.
 
Bateman ED, Emerson RJ, Cole PJ.  A study of macrophage-mediated initiation of fibrosis by asbestos and silica using a diffusion chamber technique.  British Journal of Experimental Pathology 1982; 63:414-425.
 
Benatar SR, Bateman ED.  The asbestos hazard.  South African Medical Journal 1982; 62:881-882.

Bateman ED, Westerman DE, Hewitson RP, Ferguson AD. Pneumonectomy for massive ventilated lung cysts.  Thorax 1981; 36:554-555.

Willcox PA, Benatar SR, Potgieter PD, Ferguson AD, Bateman ED.  Fibreoptic bronchoscopy.  Experience at Groote Schuur Hospital.  South African Medical Journal 1981; 60:651-654.
 
Bateman ED, Turner-Warwick M, Adelman BC. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease.  Thorax 1981; 36:654-653.
 
Westerman DE, Bateman ED, Alexander ME, Benatar SR.  The magnitude of the asthma problem in Cape Town. South African Medical Journal 1978; 53:574-577. 

LETTERS in CITED JOURNALS  
FitzGerald M, Bateman E, Hurd S, Boulet  L-P,T Haahtela T, Cruz AA, Levy ML. Eur Respir J, 2012
 
Bateman ED, Rabe KF, Calverley PMA, Goehring UM, Brose M, Bredenbröker, Fabbri L. Avoiding backward steps in COPD: Looking again at roflumilast. Eur Respir J, 2012; 39(1): 224-226.
 
Bateman ED. Letter to editor. GOAL - Asthma Control, but at what cost? American Journal of Respiratory and Critical Care Medicine 2005;172:255-6. 

Bateman ED
. Letter to the editor. The GOAL Study. Design to favor a long-acting β2-agonist. American Journal of Respiratory and Critical Care Medicine 2005;171:1061
 
Bateman ED,  Bolliger CT, Irusen E, Feldman C, Lalloo U, Richards G.  Counting the cost of dismantling specialist academic units (Letter).  Transactions 2002;46 (2):52-53.

Benatar SR, Bateman ED.  The asbestos hazard.  South African Medical Journal 1993;63:348-349.

Bateman ED.  Reversal of acute resistant asthma by beclomethasone.  South African Medical Journal 1993;83:616.
 
Ainslie GM, Bateman ED.  Lymphocyte and lymphocyte subset numbers in blood and bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis.  Thorax 1992;47:1085-1086.

ARTICLES IN JOURNALS (NON-CITED)Yorgancıoğlu A, Yardım N, Ergün P, Karlıkaya C, Kocabaş A, Mungan D, Yıldız F, Akdağ R, Keskinkılıç B, Bingöl Karakoç G, Köktürk N, Özacar R, Saçkesen C, Yüksel H, Akçay S, Altan P, Altunsu T, Arpacı N , Aytaç B, Çakır B, Çoban ÇS2, Göktaş E, Gündoğan A, Kakillioğlu T, Kosdak M, Tugay D, Khaltaev N, Cuz A, Bateman E, Baena Cagnani C, Dahl R, Bousquet J. Integration of GARD Turkey national program with other non-communicable disease plans in Turkey. Tüberküloz ve Toraks Dergisi 2010; 58(2): 213-228.   

Bateman ED.  Adverse effects of drugs on the lung.  South African Journal of Continuing Medical Education 1986; 4:84-91.

Bateman ED.  What is new in tuberculosis.  South African Family Practitioner 1994; 15:381-387.
 
Bateman ED.  The New South African National Tuberculosis Control Programme.  Specialist Medicine 1997; 8: 15-24.
 
Bateman ED. What do we mean by “asthma control”?  Specialist Medicine 2001; 23:715 -719.
 
Bateman ED. The classification, assessment and treatment of the idiopathic interstitial pneumonias. South African Respiratory Journal 2001; 7:88-96.
 
Bateman ED. The Allergic Rhinitis and its Impact on Asthma (ARIA) Initiative. Current Allergy and Clinical Immunology 2001; 14:10-13.

Bateman ED, Feldman C.  The Future of Pulmonology in South Africa: Report  on the Strategic Framework for the Modernisation of Tertiary Services. South African Respiratory Journal 2003; 9: 178-184.
 
Bateman ED.  The natural history of chronic obstructive lung diseases.  South African Journal of Continuing Medical Education 1983; 1:25-29
 14th October 2012  

Signed: Eric D Bateman